PCR Biosystems has today launched RiboShield™ RNase Inhibitor. Already an important component of several PCR Biosystems kits, this robust and reliable RNase inhibitor is, for the first time, available as a standalone product.

This upstream manufacturing platform is suitable for multiple viral applications to support the booming gene therapy market and offer a cost-effective tool for rapid response to emerging infectious diseases.

The handbook was first launched in 2017 as a comprehensive reference guide for live-cell analysis technologies, with a focus on the complete suite of Incucyte® live-cell assays and reagents.

The first project under the agreement sees the two companies work together to assess small molecule therapeutics for COVID-19.

StarBright Dyes are conjugated to a growing range of antibodies and are compatible with most flow cytometers and experimental protocols.

ZEISS today introduces the Advanced Reconstruction Toolbox for its industry-leading ZEISS Xradia 3D X-ray microscope and computed tomography systems. With the Toolbox, two modules are announced: an upgraded ZEISS OptiRecon for iterative reconstruction, and ZEISS DeepRecon, microscopy’s first commercially available deep learning reconstruction technology.

The BioScaffolder Prime from Analytik is a new affordable high-performance 3D bioprinter that delivers precision engineering in an advanced, customisable platform.

BioChromato Inc. has made a major investment to expand sales, marketing and customer support activities in international markets, most notably Europe and North America.

CPI, the Knowledge Centre for Materials Chemistry (KCMC) and the Henry Royce Institute (Royce) have announced a collaboration that will enable the organizations to work together to help UK companies develop and commercialize products that use new advanced materials.

Promega has launched its benchtop capillary electrophoresis (CE) instrument, the Spectrum Compact CE System, developed in collaboration with Hitachi High-Tech.